Showing results (71-80 of 122) with videos related to
Sort By:
Pageof 13
NPJ Schizophrenia|August 28, 2020
Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosisAlex M Dickens, Faith Borgan, Heikki Laurikainen, et al.Molecular Psychiatry|February 28, 2025
Investigating dopaminergic abnormalities in schizophrenia and first-episode psychosis with normative modelling and multisite molecular neuroimagingAlessio Giacomel, Daniel Martins, Giovanna Nordio, et al.Molecular Psychiatry|January 12, 2020
Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysisMaria Rogdaki, Maria Gudbrandsen, Robert A McCutcheon, et al.Journal of Psychopharmacology (Oxford, England)|November 22, 2013
Does human presynaptic striatal dopamine function predict social conformity?Paul R A Stokes, Aaf Benecke, Julita Puraite, et al.Neuroimage|October 9, 2018
Sex difference in brain CB1 receptor availability in manHeikki Laurikainen, Lauri Tuominen, Maria Tikka, et al.Scientific Reports|February 23, 2019
Covariance statistics and network analysis of brain PET imaging studiesMattia Veronese, Lucia Moro, Marco Arcolin, et al.Frontiers in Psychiatry|December 25, 2014
Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal ActivationCelia J A Morgan, Chris M Dodds, Hannah Furby, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 6, 2017
Kinetic modelling of [<sup>11</sup>C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysisMattia Veronese, Tiago Reis Marques, Peter S Bloomfield, et al.The Lancet. Psychiatry|June 4, 2021
Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosisBenjamin I Perry, Emanuele F Osimo, Rachel Upthegrove, et al.Schizophrenia Bulletin|March 21, 2023
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working GroupElias Wagner, Dan Siskind, Peter Falkai, et al.Pageof 13